A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.
The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...
We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.
The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...
There’s still scope for a new generation of drugs to replace weight-loss market leaders like Novo Nordisk A/S’s Wegovy, ...
Medicare released its next target list of 15 drugs to negotiate prices of, including Novo Nordisk's blockbuster GLP-1 drugs.